Profile | GDS5420 / 217173_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 97.22 | 41 |
GSM1296119 | B_lesional_pre-dose | 132.54 | 45 |
GSM1296076 | C_lesional_pre-dose | 113.35 | 44 |
GSM1296092 | D_lesional_pre-dose | 88.24 | 42 |
GSM1296103 | E_lesional_pre-dose | 105.81 | 43 |
GSM1296078 | F_lesional_pre-dose | 70.62 | 37 |
GSM1296107 | G_lesional_pre-dose | 115.5 | 42 |
GSM1296109 | H_lesional_pre-dose | 69.42 | 34 |
GSM1296080 | I_lesional_pre-dose | 39.4 | 29 |
GSM1296090 | J_lesional_pre-dose | 101.78 | 43 |
GSM1296074 | K_lesional_pre-dose | 102.18 | 44 |
GSM1296111 | L_lesional_pre-dose | 153.45 | 47 |
GSM1296099 | M_lesional_pre-dose | 135.38 | 46 |
GSM1296086 | O_lesional_pre-dose | 68.94 | 37 |
GSM1296117 | P_lesional_pre-dose | 161.92 | 47 |
GSM1296113 | Q_lesional_pre-dose | 139.39 | 44 |
GSM1296096 | R_lesional_pre-dose | 177.85 | 51 |
GSM1296105 | S_lesional_pre-dose | 47.59 | 29 |
GSM1296098 | T_lesional_pre-dose | 89.06 | 38 |
GSM1296101 | U_lesional_pre-dose | 85.75 | 39 |
GSM1296121 | V_lesional_pre-dose | 143.87 | 46 |
GSM1296088 | W_lesional_pre-dose | 90.47 | 41 |
GSM1296082 | X_lesional_pre-dose | 128.2 | 47 |
GSM1296115 | Y_lesional_pre-dose | 126.14 | 44 |
GSM1296084 | Z_lesional_pre-dose | 87.98 | 39 |
GSM1296072 | B_lesional_day8 | 56.99 | 31 |
GSM1296069 | L_lesional_day8 | 157.65 | 46 |
GSM1296071 | P_lesional_day8 | 67.41 | 32 |
GSM1296070 | Y_lesional_day8 | 61.16 | 31 |
GSM1296073 | V_lesional_day8 | 237.65 | 56 |
GSM1296034 | A_lesional_day15 | 73.98 | 36 |
GSM1296041 | G_lesional_day15 | 118.75 | 43 |
GSM1296035 | R_lesional_day15 | 99.08 | 42 |
GSM1296038 | U_lesional_day15 | 99.95 | 42 |
GSM1296047 | B_lesional_day15 | 83.33 | 36 |
GSM1296039 | E_lesional_day15 | 164.55 | 50 |
GSM1296042 | H_lesional_day15 | 76.81 | 35 |
GSM1296043 | L_lesional_day15 | 105.66 | 39 |
GSM1296037 | M_lesional_day15 | 48.3 | 29 |
GSM1296046 | P_lesional_day15 | 75.35 | 34 |
GSM1296044 | Q_lesional_day15 | 70.76 | 33 |
GSM1296045 | Y_lesional_day15 | 80.07 | 34 |
GSM1296025 | C_lesional_day15 | 29.37 | 23 |
GSM1296033 | D_lesional_day15 | 40.12 | 28 |
GSM1296027 | I_lesional_day15 | 52.18 | 34 |
GSM1296032 | J_lesional_day15 | 38.14 | 27 |
GSM1296024 | K_lesional_day15 | 31.76 | 25 |
GSM1296031 | W_lesional_day15 | 50.25 | 30 |
GSM1296028 | X_lesional_day15 | 43.74 | 29 |
GSM1296029 | Z_lesional_day15 | 55.04 | 33 |
GSM1296026 | F_lesional_day15 | 99.27 | 42 |
GSM1296030 | O_lesional_day15 | 53.97 | 35 |
GSM1296040 | S_lesional_day15 | 56.61 | 32 |
GSM1296036 | T_lesional_day15 | 82.84 | 37 |
GSM1296048 | V_lesional_day15 | 247.09 | 56 |
GSM1296059 | A_lesional_day43 | 115.97 | 44 |
GSM1296066 | G_lesional_day43 | 82.33 | 36 |
GSM1296060 | R_lesional_day43 | 108.16 | 43 |
GSM1296063 | U_lesional_day43 | 111.75 | 43 |
GSM1296064 | E_lesional_day43 | 214.96 | 54 |
GSM1296067 | H_lesional_day43 | 59.03 | 31 |
GSM1296062 | M_lesional_day43 | 84.81 | 39 |
GSM1296068 | Q_lesional_day43 | 70.67 | 32 |
GSM1296050 | C_lesional_day43 | 51.28 | 30 |
GSM1296057 | D_lesional_day43 | 70.82 | 37 |
GSM1296052 | I_lesional_day43 | 44.87 | 31 |
GSM1296054 | J_lesional_day43 | 58.66 | 33 |
GSM1296049 | K_lesional_day43 | 48.83 | 31 |
GSM1296055 | W_lesional_day43 | 72.97 | 36 |
GSM1296053 | X_lesional_day43 | 53.32 | 32 |
GSM1296058 | Z_lesional_day43 | 68.65 | 37 |
GSM1296051 | F_lesional_day43 | 51.01 | 31 |
GSM1296056 | O_lesional_day43 | 99 | 43 |
GSM1296065 | S_lesional_day43 | 162.89 | 49 |
GSM1296061 | T_lesional_day43 | 72.74 | 36 |
GSM1296095 | A_non-lesional_pre-dose | 89.89 | 40 |
GSM1296120 | B_non-lesional_pre-dose | 74.34 | 34 |
GSM1296077 | C_non-lesional_pre-dose | 41.82 | 29 |
GSM1296093 | D_non-lesional_pre-dose | 59.43 | 33 |
GSM1296104 | E_non-lesional_pre-dose | 146.92 | 47 |
GSM1296079 | F_non-lesional_pre-dose | 49.71 | 31 |
GSM1296108 | G_non-lesional_pre-dose | 63.64 | 33 |
GSM1296110 | H_non-lesional_pre-dose | 44.69 | 26 |
GSM1296081 | I_non-lesional_pre-dose | 36.1 | 28 |
GSM1296091 | J_non-lesional_pre-dose | 75.19 | 38 |
GSM1296075 | K_non-lesional_pre-dose | 54.31 | 33 |
GSM1296112 | L_non-lesional_pre-dose | 113.75 | 40 |
GSM1296100 | M_non-lesional_pre-dose | 48.05 | 30 |
GSM1296087 | O_non-lesional_pre-dose | 50.81 | 33 |
GSM1296118 | P_non-lesional_pre-dose | 56.47 | 29 |
GSM1296114 | Q_non-lesional_pre-dose | 80.78 | 35 |
GSM1296097 | R_non-lesional_pre-dose | 76.89 | 37 |
GSM1296106 | S_non-lesional_pre-dose | 133.39 | 45 |
GSM1296102 | U_non-lesional_pre-dose | 43 | 28 |
GSM1296122 | V_non-lesional_pre-dose | 82.08 | 36 |
GSM1296089 | W_non-lesional_pre-dose | 75.4 | 36 |
GSM1296083 | X_non-lesional_pre-dose | 40.46 | 28 |
GSM1296116 | Y_non-lesional_pre-dose | 71.52 | 32 |
GSM1296085 | Z_non-lesional_pre-dose | 26.01 | 21 |